Search research articles
Contact Us
Filters
Showing results (241-250 of 259) with videos related to
Page
of 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2021
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses
Kelly J Norsworthy, Xin Gao, Chia-Wen Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2019
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Emily Y Jen, Xin Gao, Liang Li, et al.
Psychoneuroendocrinology
|
April 26, 2023
Towards a consensus definition of allostatic load: a multi-cohort, multi-system, multi-biomarker individual participant data (IPD) meta-analysis
Cathal McCrory, Sinead McLoughlin, Richard Layte, et al.
Leukemia
|
June 11, 2020
Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis
Kelly J Norsworthy, Armen Avagyan, Steven T Bird, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2014
U.S. Food and drug administration approval: obinutuzumab in combination with chlorambucil for the treatment of previously untreated chronic lymphocytic leukemia
Hyon-Zu Lee, Barry W Miller, Virginia E Kwitkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2015
FDA Approval: Blinatumomab
Donna Przepiorka, Chia-Wen Ko, Albert Deisseroth, et al.
The Oncologist
|
July 1, 2021
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health
Elaine Chang, Lorraine Pelosof, Steven Lemery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2013
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma
Thomas M Herndon, Albert Deisseroth, Edvardas Kaminskas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2015
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma
Barry W Miller, Donna Przepiorka, R Angelo de Claro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2018
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C Krauss, Xin Gao, Liang Li, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 259) with videos related to
Sort By:
Page
of 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2021
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses
Kelly J Norsworthy, Xin Gao, Chia-Wen Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2019
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Emily Y Jen, Xin Gao, Liang Li, et al.
Psychoneuroendocrinology
|
April 26, 2023
Towards a consensus definition of allostatic load: a multi-cohort, multi-system, multi-biomarker individual participant data (IPD) meta-analysis
Cathal McCrory, Sinead McLoughlin, Richard Layte, et al.
Leukemia
|
June 11, 2020
Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis
Kelly J Norsworthy, Armen Avagyan, Steven T Bird, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2014
U.S. Food and drug administration approval: obinutuzumab in combination with chlorambucil for the treatment of previously untreated chronic lymphocytic leukemia
Hyon-Zu Lee, Barry W Miller, Virginia E Kwitkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2015
FDA Approval: Blinatumomab
Donna Przepiorka, Chia-Wen Ko, Albert Deisseroth, et al.
The Oncologist
|
July 1, 2021
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health
Elaine Chang, Lorraine Pelosof, Steven Lemery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2013
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma
Thomas M Herndon, Albert Deisseroth, Edvardas Kaminskas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2015
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma
Barry W Miller, Donna Przepiorka, R Angelo de Claro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2018
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C Krauss, Xin Gao, Liang Li, et al.
Page
of 26